Archive for October, 2008

 

Rasilez HCT(R), Single-pill Combination Of Rasilez(R) And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure

October 18th, 2008

Rasilez HCT® (aliskiren and hydrochlorothiazide), a single-pill combination of two high blood pressure medicines - first-in-class direct renin inhibitor Rasilez®[1] (aliskiren) and the diuretic hydrochlorothiazide (HCT) - has been approved by Swissmedic as a new treatment for high blood pressure.
High blood pressure is estimated to affect nearly

Read full article   »   Comments Off

Sunshine could help fix male infertility

October 17th, 2008

Men’s Health News
Australian fertility experts say a dose of daily sunshine could help men with fertility problems and they suggest couples struggling to conceive should consider getting out in the sunshine more often.
According to Dr. Anne Clark, the medical director of the Fertility First assisted reproduction clinic in Sydney, blood tests of 794 men who […]

Read full article   »   Comments Off

Men who have too much calcium in their bloodstreams may increase risk of fatal prostate cancer

October 4th, 2008

Men’s Health News
Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin.
"We show that men in upper range of the normal distribution of serum calcium subsequently have an almost three-fold […]

Read full article   »   Comments Off

Study: Stress & Anxiety Make Your Allergies Worse

October 2nd, 2008

If you’re one of the millions of Americans who suffer from allergies,* this story is for you. Scientists have determined that when it comes to allergies, it’s not just things like pets or pollen that are making you miserable- it might also be your job or your relationship. A new study is proving that there […]

Read full article   »   Comments Off

Efficacy, Dosage Concerns Unresolved On Sublingual Immunotherapy

October 1st, 2008

Although sublingual immunotherapy (SLIT) is used in Europe and other countries, experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle say questions remain unanswered regarding its effectiveness, appropriate use, dosage, and safety of administration.
"Sublingual immunotherapy has gained wide acceptance in the treatment of allergic disease throughout Europe […]

Read full article   »   Comments Off